During the past decade, Helen Rollason Cancer Care Centre at North Middlesex Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" #1 sponsor was "Medical Research Council" with 2 trials, followed by "Velindre NHS Trust" with 2 trials sponsored, "Anglo Celtic Cooperative Oncology Group" with 1 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "Lisette Nixon" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Extrahepatic Bile Duct Cancer" (2 trials), "Gallbladder Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" in a lesser frequency.

Most popular intervention types in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" are "Drug" (10 trials), "Procedure" (6 trials), "Radiation" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (5 trials), "adjuvant therapy" (4 trials), "quality-of-life assessment" (3 trials), "cetuximab" (2 trials) and "cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Helen Rollason Cancer Care Centre at North Middlesex Hospital" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Helen Rollason Cancer Care Centre at North Middlesex Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Helen Rollason Cancer Care Centre at North Middlesex Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helen Rollason Cancer Care Centre at North Middlesex Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".